Seminar: Eliminating Long-term Complications After Orbital Floor Reconstruction

Dr Stephanie Ming Young and Dr G Krishana Ananda and talks about:
- Avoiding long-term complications in orbital floor repairs
- Managing orbital floor fractures with regenerative implants
0:00 Overview of Osteopore
05:25 Dr Stephanie Ming Young
24:41 Dr G Krishana Ananda
54:00 Q&A
About our speakers:
Dr Stephanie Ming Young (MBBS, M.Med (Ophth), FRCOphth (London), FAMS)
Dr Young is a Senior Consultant eye surgeon and Director of Ophthalmic Plastic & Reconstructive Surgery at Eagle Eye Centre, Singapore. She has a special interest in eyelid, lacrimal and orbital surgery.
Dr Young is active in Oculoplastic-related research and has published more than 40 papers in peer-reviewed journals and several book chapters. She has won awards including: American Academy of Ophthalmology Achievement Award (2019), Asia-Pacific Academy of Ophthalmology Best Scientific Paper (2018, 2019), American Academy of Ophthalmology Best Poster Award (2014, 2015 & 2017) and the Wong Hock Boon Society Outstanding Mentor Award 2017.
Dr G Krishana Ananda (BDS(UM), OMFS(UM))
Dr GK has over a decade of surgical experience in OMF surgery. Dr GK is also a Consultant OMF in Gleneagles Hospital, Johore. He was previously the Head of Department for Hospital Enche' Besar Hajjah Kalsom.
Dr GK specializes in the repair of Cranio-Maxillofacial deformities, Temporomandibular Joint Disorders, Salivary Gland Tumors, and Obstructive Sleep Apnea.
About Osteopore
Osteopore products are developed and manufactured using state of the art technology, and strictly adhere to all the international quality standards to ensure the delivery of safe and effective innovative clinical solutions.
In 1996, a team of biomaterial engineers in Singapore initiated research of a novel 3D manufacturing platform to produce tissue scaffolds. The company has gained global recognition for the innovative engineering for development of new tissue engineering solutions to meet medical implant needs.
The advent of tissue engineering has provided a paradigm shift in treatment options to meet the needs of orthopaedic and plastic-reconstructive surgeons as alternates to permanent and autograft implants. The clinical needs addressed are the provision of a tissue engineered scaffolds that allow complete tissue regeneration, whilst providing appropriate load bearing structural integrity, and the avoidance of the complications of patient grafts and permanent implants.
The Osteopore products are composed of an FDA approved and clinically proven resorbable polymer ( polycaprolactone- PCL) . PCL has the characteristics of a predictable resorption profile and malleability, whilst providing mechanical strength similar to trabecular bone.